Skip to main content

Table 1 Patient characteristics

From: Modified endoscopic transnasal orbital apex decompression in dysthyroid optic neuropathy

Characteristics N = 42
Female (%) 18 (43)
Age (years) 57.30 ± 9.29
BMI (kg/m2) 24.40 ± 2.71
Follow up time (months) 6 (2–8)
Medical background
 Diabetes (%) 6 (14)
 Hypertension (%) 15(36)
Thyroid
 Hyperthyroidism (%) 38 (90)
 Hypothyroidism (%) 1 (2)
 Normal (%) 3 (7)
 Duration of Thyroid dysfunction (months) 12 (7.75–36)
 Duration of TAO (months) 10.5 (6–12)
 Duration of DON (months) 6 (2–11)
Serum
 FT3 (pg/ml) 5.27 (4.44–5.94)
 FT4 (ng/dl) 17.25 (13.5–20.94)
 TSH (μIU/ml) 0.94 (0.08–3.78)
 TG (ng/ml) 43.47 (10.44–181)
 TGAb (IU/ml) 12.05 (10–18.44)
 TPOAb (IU/ml) 21.55 (11.32–56.16)
  1. BMI= body mass index, TAO= thyroid associated ophthalmopathy, DON= dysthyroid optic neuropathy, FT3= free triiodothyronine, FT4= free thyroxinem, TSH= thyroid stimulating hormone, TG= thyroglobulin, TGAb= thyroglobulin antibody, TPOAb= thyroid peroxidase antibody